Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 2 |
NetGPI | no | yes: 0, no: 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
Related structures:
AlphaFold database: E9AEM5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 43 | 45 | PF00675 | 0.443 |
CLV_NRD_NRD_1 | 48 | 50 | PF00675 | 0.444 |
CLV_PCSK_KEX2_1 | 42 | 44 | PF00082 | 0.444 |
CLV_PCSK_KEX2_1 | 47 | 49 | PF00082 | 0.495 |
CLV_PCSK_PC7_1 | 43 | 49 | PF00082 | 0.404 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.461 |
DEG_SPOP_SBC_1 | 62 | 66 | PF00917 | 0.709 |
DOC_MAPK_RevD_3 | 27 | 43 | PF00069 | 0.399 |
DOC_USP7_MATH_1 | 23 | 27 | PF00917 | 0.399 |
DOC_USP7_MATH_1 | 62 | 66 | PF00917 | 0.773 |
LIG_APCC_ABBAyCdc20_2 | 7 | 13 | PF00400 | 0.388 |
LIG_BRCT_BRCA1_1 | 121 | 125 | PF00533 | 0.399 |
LIG_DCNL_PONY_1 | 1 | 4 | PF03556 | 0.456 |
LIG_EH1_1 | 124 | 132 | PF00400 | 0.399 |
LIG_FHA_1 | 111 | 117 | PF00498 | 0.253 |
LIG_FHA_1 | 94 | 100 | PF00498 | 0.324 |
LIG_FHA_2 | 51 | 57 | PF00498 | 0.757 |
LIG_FHA_2 | 99 | 105 | PF00498 | 0.399 |
LIG_IBAR_NPY_1 | 74 | 76 | PF08397 | 0.635 |
LIG_LIR_Gen_1 | 122 | 131 | PF02991 | 0.399 |
LIG_LIR_Nem_3 | 122 | 128 | PF02991 | 0.399 |
LIG_PDZ_Class_2 | 133 | 138 | PF00595 | 0.679 |
LIG_SH2_CRK | 76 | 80 | PF00017 | 0.634 |
LIG_SH2_STAT5 | 119 | 122 | PF00017 | 0.324 |
LIG_SH2_STAT5 | 20 | 23 | PF00017 | 0.484 |
LIG_SH2_STAT5 | 86 | 89 | PF00017 | 0.505 |
LIG_SH2_STAT5 | 98 | 101 | PF00017 | 0.312 |
MOD_CK1_1 | 22 | 28 | PF00069 | 0.359 |
MOD_CK2_1 | 50 | 56 | PF00069 | 0.757 |
MOD_CK2_1 | 98 | 104 | PF00069 | 0.324 |
MOD_GlcNHglycan | 21 | 24 | PF01048 | 0.414 |
MOD_GlcNHglycan | 91 | 94 | PF01048 | 0.352 |
MOD_GSK3_1 | 19 | 26 | PF00069 | 0.359 |
MOD_GSK3_1 | 89 | 96 | PF00069 | 0.324 |
MOD_NEK2_1 | 126 | 131 | PF00069 | 0.332 |
MOD_NEK2_2 | 23 | 28 | PF00069 | 0.349 |
MOD_NEK2_2 | 93 | 98 | PF00069 | 0.324 |
MOD_Plk_4 | 126 | 132 | PF00069 | 0.399 |
MOD_Plk_4 | 23 | 29 | PF00069 | 0.377 |
MOD_Plk_4 | 93 | 99 | PF00069 | 0.324 |
TRG_ENDOCYTIC_2 | 76 | 79 | PF00928 | 0.633 |
TRG_ENDOCYTIC_2 | 8 | 11 | PF00928 | 0.447 |
TRG_ER_diArg_1 | 41 | 44 | PF00400 | 0.649 |
TRG_ER_diArg_1 | 47 | 49 | PF00400 | 0.630 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IHP8 | Leishmania donovani | 79% | 98% |